Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an 'infinite dilution' procedure

Biochemical Pharmacology

Volumn 53, Issue 6, 1997, Pages 795-800

  Christopoulos, Arthur ^a   Lanzafame, Alfred ^a   Ziegler, Albrecht ^a,b   Mitchelson, Fred ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

allosteric interaction; bisquaternary antagonist; co operativity; dissociation kinetics; gallamine; muscarinic acetylcholine M2 receptors

Indexed keywords

ATROPINE; GALLAMINE; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; HEART ATRIUM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

ALLOSTERIC REGULATION; ANIMALS; FEMALE; GALLAMINE TRIETHIODIDE; GUINEA PIGS; HEART ATRIA; KINETICS; MALE; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES;

EID: 0030944020     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00814-3     Document Type: Article

References (16)

1. Lee NH and El-Fakahany EE, Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42: 199-205, 1991.
2. Delean A and Rodbard D, Kinetics of cooperative binding. In: The Receptors: A Comprehensive Treatise (Ed. O'Brien, RD), pp. 143-192. Plenum Press, New York, 1979.
3. Henis YI, Kloog Y and Sokolovsky M, Allosteric interactions of muscarinic receptors and their regulation by other membrane proteins. In: The Muscarinic Receptors (Ed. Brown, JH), pp. 377-418. Humana Press, Inc., New York, 1989.
4. 3H]N-methylscopolamine dissociation from muscarinic receptors affected by low concentrations of allosteric modulators. Eur J Pharmacol (Molec Pharmacol Sect) 290: 259-262, 1995.
5. Ehlert FJ, Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33: 187-194, 1988.
6. Miller RG, Simultaneous Statistical Inference. McGraw Hill, New York, 1966.
7. DeMeyts P, The structural basis of insulin and insulin-like growth factor-I (IGF-1) receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signalling, Diabetologia 37: S135-S148, 1994.
8. Stockton JM, Birdsall NJM, Burgen ASV and Hulme EC, Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23: 551-557, 1983.
9. Waelbroeck M, Robberecht P, De Neff P and Christophe J, Effects of d-tubocurarine on rat cardiac muscarinic receptors. A comparison with gallamine. J Recept Res 8: 787-808, 1988.
10. Michel AD, Delmondo RE, Lopez M and Whiting RL, On the interaction of gallamine with muscarinic receptor subtypes. Eur J Pharmacol 182: 335-345, 1990.
11. 2 muscarine receptors. Mol Pharmacol 46: 105-114, 1994.
12. Lüllmann H, Ohnesorge FK, Schauwecker G-C and Wassermann O, Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane bis-ammonium compounds. Eur J Pharmacol 6: 241-247, 1969.
13. Clark AL and Mitchelson F, The inhibitory effects of gallamine on muscarinic receptors. Br J Pharmacol 58: 323-331, 1976.
14. Choo LK and Mitchelson F, Characterization of the antimus-carinic effect of heptane-l,7-bis-(dimethyl-3'-phthal-imidopropyl ammonium bromide). Eur J Pharmacol 162: 429-435, 1989.
15. Tuček S and Proska J, Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16: 205-212, 1995.
16. Lazareno S and Birdsall NJM, Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48: 362-378, 1995.